Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 7.01, 9.01 · 8-K

VERADIGM INC

MDRXOTCEQUITYCurrent

Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. As previously disclosed, on August 17, 2026, the Company announced that members of the Company's management would participate in the 2026 Jefferies Healthcare Services and Technology Conference in Nashville, Tennessee on September 15, 2026 and the Deutsche Bank 2026 Healthcare Summit in New York, New York on September 16, 2026.…

Filed Sep 8, 2026Accepted Sep 8, 2026, 9:00 AM EDTCIK 1124804Accession 0001193125-26-384471
Share

Company context

Veradigm has a proven history of delivering clinical and revenue cycle solutions that help independent practices improve outcomes and financial performance. Our AI-forward data and technology also help over 20,000 provider practices connect with health plans and biopharma to eliminate inefficiencies, close care gaps, and create a more affordable health system. © 2026 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or Company names are the property of their respective holders, all rights reserved.

Current securities

Historical securities (1)

Recent company filings

  1. NT 10-Q filingNov 10, 2026
  2. Regulation FD DisclosureSep 15, 2026
  3. Other EventsSep 8, 2026
  4. Regulation FD DisclosureAug 17, 2026
  5. NT 10-Q filingAug 11, 2026

Registered securities in this filing

VERADIGM INC. · 8-K · Filed 2026-09-08

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, par value $0.01 per share

Symbol
MDRX
Exchange
NONE
Classification
COMMON
Filing context

Context: C_cdff5d6b-3c91-4475-9aea-388aa7d1aaf7

Dimensions: Not supplied

Accession 000119312526384471 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 7.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. As previously disclosed, on August 17, 2026, the Company announced that members of the Company's management would participate in the 2026 Jefferies Healthcare Services and Technology Conference in Nashville, Tennessee on September 15, 2026 and the Deutsche Bank 2026 Healthcare Summit in New York, New York on September 16, 2026. On September 8, 2026, the Company issued a press release announcing an updated presentation time for the 2026 Jefferies Healthcare Services and Technology Conference. The Company's fireside chat, previously scheduled for 4:10 PM CT on September 15, 2026, will now take place at 3:35 PM CT on September 15, 2026. This update relates solely to the timing of the Company's presentation at the Jefferies conference and does not affect the previously announced details regarding the Deutsche Bank 2026 Healthcare Summit. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference. The information furnished pursuant to this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Filed exhibits (1)
EX-99.1 (by filename) mdrx-ex99_1.htm

EX-99.1 2 mdrx-ex99_1.htm EX-99.1 EX-99.1 Exh. 99.1 Veradigm Announces Updated Presentation Time for Upcoming Investor Conference September 08, 2026 CHICAGO--(BUSINESS WIRE) - September 8, 2026 -- Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that it will now present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15th at 3:35PM CT. A live webcast of the fireside chat will be available at the Veradigm investor relations website. About Veradigm® Veradigm has a proven history of delivering clinical and revenue cycle solutions that help independent practices improve outcomes and financial performance. Our AI-forward data and technology also help over 20,000 provider practices connect with health plans and biopharma to eliminate inefficiencies, close care gaps, and create a more affordable health system. © 2026 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or Company names are the property of their respective holders, all rights reserved. For more information conta…

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.